Evidence map›Paper›PMID 34361577›Full record

ArticleMolecules (Basel, Switzerland)2021

Structure-Based Designing, Solvent Less Synthesis of 1,2,3,4-Tetrahydropyrimidine-5-carboxylate Derivatives: A Combined In Vitro and In Silico Screening Approach.

Uzma Arshad, Sibtain Ahmed, Nusrat Shafiq, Zaheer Ahmad, Aqsa Hassan, Naseem Akhtar, Shagufta Parveen, Tahir Mehmood

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. ACS omega · 2026
    Article
  3. Article
  4. Article
  5. RSC advances · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Uzma ArshadDepartment of Chemistry, Government College Women University Faisalabad, Faisalabad 38000, Pakistan.ORCID 0000-0003-4694-7761
Sibtain AhmedScripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0003-0708-3278
Nusrat ShafiqDepartment of Chemistry, Government College Women University Faisalabad, Faisalabad 38000, Pakistan.ORCID 0000-0002-3270-4227
Zaheer AhmadDepartment of Chemistry, University of Wah, Rawalpindi 47000, Pakistan.
Aqsa HassanDepartment of Chemistry, Government College Women University Faisalabad, Faisalabad 38000, Pakistan.
Naseem AkhtarDepartment of Chemistry, Government Sadiq College Women University, Bahawalpur 63000, Pakistan.
Shagufta ParveenDepartment of Chemistry, Government College Women University Faisalabad, Faisalabad 38000, Pakistan.
Tahir MehmoodInstitute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore 54000, Pakistan.ORCID 0000-0002-7354-328X
Government College Women University Faisalabad · PKGovernment Sadiq College Women University · PKScripps Institution of Oceanography · USUniversity of Veterinary and Animal Sciences · PKUniversity of Wah · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn this study, small molecules possessing tetrahydropyrimidine derivatives have been synthesized having halogenated benzyl derivatives and carboxylate linkage. As previously reported, FDA approved halogenated pyrimidine derivatives prompted us to synthesize novel compounds in order to evaluate their biological potential. METHODOLOGY: Eight pyrimidine derivatives have been synthesized from ethyl acetoacetate, secondary amine, aromatic benzaldehyde by adding catalytic amount of CuCl

resultsAfter combined experimental and virtual screening

Indexed as

Antineoplastic AgentsAntioxidantsHypoglycemic AgentsMolecular Docking SimulationPyrimidinesDrug Screening Assays, AntitumorHep G2 CellsHumansAntineoplastic AgentsAntioxidantsHypoglycemic AgentsPyrimidinesDFTin silicoin vitromolecular dockingMTTpyrimidineQSARsolvent less

Identifiers

PMID34361577
PMCPMC8348070
OpenAlexW3186237982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.